; (5) the rate of patients returning to work in general, and after receiving a prosthetic device comparable to other assistive technologies; (6) reductions in long-term assistive technology services and supports; (7) with respect to those using assistive technologies, policies to reduce falls and secondary complications, such as diabetes, heart disease, vascular disease, and others; and (8) the amount expended by individual entities on prosthetics relative to total amount expended by such entities.